Cargando…
Nanosized Drug Delivery Systems to Fight Tuberculosis
Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular therapies are long, complex, and have severe side effects that result in low patient compliance. In this context, nanosized drug delivery systems (DDSs) have the potential to optimize the treatment’s effi...
Autores principales: | Bourguignon, Tom, Godinez-Leon, Jesus Alfredo, Gref, Ruxandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964171/ https://www.ncbi.nlm.nih.gov/pubmed/36839715 http://dx.doi.org/10.3390/pharmaceutics15020393 |
Ejemplares similares
-
Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with Microbiota
por: Karavolos, Michail, et al.
Publicado: (2016) -
Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023) -
Solid-State NMR Spectroscopy: A Key Tool to Unravel the Supramolecular Structure of Drug Delivery Systems
por: Porcino, Marianna, et al.
Publicado: (2021) -
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
por: Lv, Li, et al.
Publicado: (2021) -
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)